Stock price when the opinion was issued
It was a good quarter. But it is important to note that one quarter does not make a trend, and there is still lots of work to be done here. It is still in turnaround mode. It still has a massive amount of debt. It is cheap, though, and the quarter might see shorts start to cover a bit. So the trend will likely be 'up' and the worst 'could' be over here. But there remains plenty of risk and we would prefer to see another quarter or two of continued improvement, and even pay more once the turn is indeed fully established and on a firm foothold. Much could still go wrong here.
Unlock Premium - Try 5i Free
One of the largest phramacies int he US. In the past year they bought several hunreds Rite-Aids, giving them a needed footprint in the American northeast. Cheap with less than 10x earnings. There are worries of Amazon coming into this sector, but Walgreens won't roll over and let them take over. They enjouy a good growth rate. (Analysts' price target $81.25)